Lepzacitinib [2321488-47-3]

TargetMol Chemicals

Lepzacitinib [2321488-47-3]

14

Chemical

Research Use Only

Lepzacitinib

C18H21N5O3

355.39

Lepzacitinib, a Janus kinase inhibitor, specifically targets JAK 1/3. It demonstrates an anti-inflammatory effect and efficacy in inhibiting atopic dermatitis as well as other skin diseases [1].

3 years

N(C1=C2C(=NC=C1C(OCC)=O)NC=C2)[C@H]3CN(C(CC#N)=O)CCC3

-20°C

12352200